Silver Book Fact

Murphy K, Topel R. The Value of Health and Longevity. J Political Econ. 2006; 114(5): 871-904. https://www.dartmouth.edu/~jskinner/documents/MurphyTopelJPE.pdf

Reference

Title
The Value of Health and Longevity
Publication
J Political Econ
Publication Date
2006
Authors
Murphy K, Topel R
Volume & Issue
Volume 114, Issue 5
Pages
871-904
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • The standard treatment for prostate cancer used to require radical prostatectomy. Now, less invasive therapies like brachytherapy have been shown to have equal outcomes with fewer side effects.  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in development is designed to induce a powerful immune response to melanoma.  
  • There are nearly 14.5 million people in the U.S. living with a history of cancer.  
  • Between August 2004 and July 2014, the FDA approved: Six new anticancer therapeutics Five new uses for previously approved anticancer therapeutics Two new uses for imaging agents One new use for a screening test